Search results

Selected filters:

Law & Policy
News

Article type

Topic

Sector

Regions

Year

342 results found for your search

Sort options
14 August 2019

USPTO Director Iancu set to keynote IAM’s patent litigation event as 101 legislation debate continues

American Express, Nokia, Google, Nasdaq, Volkswagen, Novartis and Merck executives among the final speakers revealed for prestigious November conference in Washington DC

23 July 2019

It's security, stupid - why it's time to see the wood from the trees in the FTC's case against Qualcomm

If the US chipmaker’s recent court defeat stands then the US risks ceding to China a central role in the development of 5G and future wireless technology

17 July 2019

Despite huge potential, patent operations at Chinese universities lag international standards

Technology transfer and commercialisation are buzzwords in China and attract more attention everyday. But before widespread IP-based private-public partnerships develop, there are significant systemic hurdles to overcome

13 July 2019

<em>New York Times</em>’ seizure call shows how far the tide is turning against pharma IP

The newspaper’s controversial proposal is stark demonstration of the mounting patent pressure the life sciences sector is under in the US

10 July 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month

09 July 2019

Incorrectly naming an RPI will not derail an IPR, Federal Circuit rules

In Mayne Pharma, the court upheld a PTAB final written decision invalidating a patent despite the owner’s objection that all real-parties-in-interest were not properly named in the original review petition

23 June 2019

Rubio’s Huawei proposal should worry US tech, pharma companies

Letting the executive branch neutralise patents whose owners it doesn’t like would weaken the US patent system and invite retaliation by China

21 June 2019

SK Innovation fights US trade secrets suit with Korean defamation case

Battery maker will argue that LG Chem’s US trade secret litigation is against the national interest

19 June 2019

What to do with conflicting testimony on patent eligibility

Former CAFC Chief Judge Michel: “If the public debate is confused by unreliable statements of ill-informed or overzealous advocates, the US will decline and its future will fade.”

17 June 2019

IPBC Global 2019 – Day One highlights

All the big stories from the first full day of the world’s pre-eminent conference about IP value creation

14 June 2019

“First do no harm” should be the guiding light of all attempts at patent reform

The current debate in the US around legislative changes to the eligible subject matter regime stands in marked contrast to the one triggered by the Innovation Act between 2013 and 2016

12 June 2019

IAM and sister publication GDR launch major data event

The Data Business Congress will take place in San Jose, CA, next February with the focus on the capture, protection, management, exploitation and monetisation of one of the pivotal assets of the 21st century

08 June 2019

Alice inventor - why more needs to be done on the Tillis and Coons 101 proposal

In this opinion piece, Ian K Shepherd - the man whose invention was at the heart of the pivotal SCOTUS decision - explains what the current patentable subject matter reform draft gets wrong 

04 June 2019

The SEP state of play in Europe’s major jurisdictions

Recent decisions in Germany, the UK, the Netherlands and France have shed much greater light on where the continent’s top patent litigation venues are heading on FRAND-related disputes